Pharma/fine chemicals roundup—16 April

11:38 AM | April 16, 2013 | Deepti Ramesh

FDA’s self-identification process for 2014 begins in May The US FDA says that the generic drug facility self-identification reporting period for fiscal-year 2014 will begin on 1 May 2013 and close...